of abdominal wall fat (abdominoplasty) and had moderate to severe pain. Participants were randomly assigned to receive oliceridine, placebo or an approved drug to treat pain (morphine) for 24 hours intravenously. Neither the participants nor the health care providers knew which treatment was being given until after the trial was completed. All participants were allowed to use a rescue pain medication, if the pain was not well controlled using the trial medications.

To assess the benefits of oliceridine, participants used a numerical scale